Linked Life Data

11883361

Source:http://linkedlifedata.com/resource/pubmed/id/11883361

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2002-3-8
pubmed:abstractText
The measurement of the nuchal translucency is an important marker to detect a vast number of fetal anomalies. Lately the nuchal translucency has been used increasingly as a screening method to find chromosomal anomalies especially for trisomy 21. Beside a high incidence of chromosomal defects one assumes a high risk of rare syndromes and other associated anomalies such as heart defects, skeletal anomalies, cerebral anomalies, diaphragmatic hernias, as well as of an intrauterine death. In view of abortion rate, detection rate of chromosomal anomalies, other fetal anomalies and rare syndromes we evaluated in this study the pregnancy outcome after nuchal translucency measurement, and discuss a concept for its management.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1661-8157
pubmed:author
pubmed:issnType
Print
pubmed:day
13
pubmed:volume
91
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
261-5
pubmed:dateRevised
2008-6-10
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
[Pregnancy outcome in 1,252 fetuses after nuchal translucency measurement in the 1st trimester].
pubmed:affiliation
Universitäts-Frauenklink, Basel. hornere@uhbs.ch
pubmed:publicationType
Journal Article, English Abstract